TOKYO, JAPAN - October 10, 2017 - Terumo Corporation (TSE: 4543) today provided an update on the impact to its manufacturing as a result of Hurricane Maria.
In the aftermath of Hurricane Maria, Terumo has been working diligently to assess the impact to its operations in Caguas, Puerto Rico, where Terumo manufactures the Angio-Seal™ Vascular Closure product line. The safety of 261 Terumo associates and their families located on the island remains Terumo's top priority. As of October 6, Terumo has accounted for 100% of the associates. Terumo's outreach to them is ongoing and Terumo is providing relief assistance to them.
Terumo has been suspending its manufacturing since September 20. The facility sustained minimal structural damage and Terumo is in the process of making repairs. Terumo is doing everything possible to return to normal operations and provide the Angio-Seal™ family of products to its customers and patients.
The impact of the disaster on Terumo's business performance is being examined. Further details regarding the impact will be disclosed, as needed, once the analysis is completed.
Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 28,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.